Immuron Limited [NASDAQ: IMRN] stock went on an upward path that rose over 24.44% on Wednesday, amounting to a one-week price increase of more than 35.48%. The company report on November 11, 2020 that US DoD Naval Medical Research Center Reports Positive Immunological Responses to Vaccine.
NMRC demonstrated functional antibodies in new oral therapeutic targeting Campylobacter and ETEC.
Over the last 12 months, IMRN stock rose by 158.46%. The one-year Immuron Limited stock forecast points to a potential downside of -38.39. The average equity rating for IMRN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $47.06 million, with 5.60 million shares outstanding and 3.82 million shares in the current float. Compared to the average trading volume of 102.15K shares, IMRN stock reached a trading volume of 4584567 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Immuron Limited [IMRN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMRN shares is $6.07 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMRN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Immuron Limited is set at 0.65 The Price to Book ratio for the last quarter was 4.77.
IMRN Stock Performance Analysis:
Immuron Limited [IMRN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.48. With this latest performance, IMRN shares gained by 2.56% in over the last four-week period, additionally plugging by 334.38% over the last 6 months – not to mention a rise of 158.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMRN stock in for the last two-week period is set at 65.77, with the RSI for the last a single of trading hit 75.45, and the three-weeks RSI is set at 59.52 for Immuron Limited [IMRN]. The present Moving Average for the last 50 days of trading for this stock 7.44, while it was recorded at 6.88 for the last single week of trading, and 5.87 for the last 200 days.
Insight into Immuron Limited Fundamentals:
Immuron Limited [IMRN] Insider Position Details
3 institutional holders increased their position in Immuron Limited [NASDAQ:IMRN] by around 43,061 shares. Additionally, 3 investors decreased positions by around 6,076 shares, while 2 investors held positions by with 103,025 shares. The mentioned changes placed institutional holdings at 152,162 shares, according to the latest SEC report filing. IMRN stock had 2 new institutional investments in for a total of 33,061 shares, while 3 institutional investors sold positions of 6,076 shares during the same period.